Ark Therapeutics Regulatory News (AKT)



Regulatory News for Ark Therapeutics (AKT)


Share Price: 0.445Bid: 0.42Ask: 0.47Change: 0.02 (+4.71%)Riser - Ark Ther Grp
Spread: 0.05Spread as %: 11.90%Open: 0.45High: 0.45Low: 0.445Yesterday’s Close: 0.425





Director Dealings

Fri, 18th May 2012 12:01

RNS Number : 6662D
Ark Therapeutics Group PLC
18 May 2012
 

?

18 May 2012

 

Ark Therapeutics Group plc

 

Directors' Share Dealing

 

 

Ark Therapeutics Group plc (LSE: AKT) ("the "Company") has received notification that on 17 May 2012 Peter Keen, Non-Executive Director, purchased 750,000 ordinary shares of 1 pence each in the Company through his Self Invested Pension Plan at a price of 2.85 pence per share.

 

As previously announced, Peter Keen retired as a Director with effect from the conclusion of yesterday's Annual General Meeting of the Company.

 

 

For further information please contact:

 

Ark Therapeutics Group plc


Dr Edward Bliss, Company Secretary

+44 (0)20 7388 7722

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSKMGMKGRRGZZM






DateSourceHeadlineCategory
14-Jun-13 16:40RNSSecond Price Monitoring ExtnCompany Announcement - General
14-Jun-13 16:35RNSPrice Monitoring ExtensionCompany Announcement - General
04-Jun-13 14:48RNSBlocklisting Six Monthly ReturnCompany Announcement - General
24-May-13 16:40RNSSecond Price Monitoring ExtnCompany Announcement - General
24-May-13 16:35RNSPrice Monitoring ExtensionCompany Announcement - General
17-May-13 07:00RNSInterim Management StatementResults and Trading Reports
16-May-13 13:20RNSHolding(s) in CompanyHolding(s) in Company
08-May-13 18:09RNSHolding(s) in CompanyHolding(s) in Company
08-May-13 17:47RNSHolding(s) in CompanyHolding(s) in Company
02-May-13 13:45RNSHolding(s) in CompanyHolding(s) in Company
01-May-13 16:35RNSPrice Monitoring ExtensionCompany Announcement - General
30-Apr-13 07:00RNSFinal ResultsResults and Trading Reports
26-Apr-13 16:50RNSHolding(s) in CompanyHolding(s) in Company
24-Apr-13 15:47RNSHolding(s) in CompanyHolding(s) in Company
26-Mar-13 16:40RNSSecond Price Monitoring ExtnCompany Announcement - General
26-Mar-13 16:35RNSPrice Monitoring ExtensionCompany Announcement - General
22-Mar-13 11:50RNSHolding(s) in CompanyHolding(s) in Company
20-Mar-13 13:15RNSHolding(s) in CompanyHolding(s) in Company
19-Mar-13 09:47RNSHolding(s) in CompanyHolding(s) in Company
15-Mar-13 12:01RNSTermination of Offer Period and Rule 10.8 WaiverCompany Announcement - General
26-Feb-13 17:35RNSHolding(s) in CompanyHolding(s) in Company
25-Feb-13 11:27RNSHolding(s) in CompanyHolding(s) in Company
22-Feb-13 14:41RNSHolding(s) in CompanyHolding(s) in Company
21-Feb-13 13:24PRNABERFORTH PARTNERS LLP - Form 8.3 - Ark Therapeutics plcMergers, Acquisitions and Disposals
21-Feb-13 10:56RNSHolding(s) in CompanyHolding(s) in Company
20-Feb-13 12:54PRNABERFORTH PARTNERS LLP - Form 8.3 - Ark Therapeutics plcMergers, Acquisitions and Disposals
19-Feb-13 16:40RNSSecond Price Monitoring ExtnCompany Announcement - General
19-Feb-13 16:35RNSPrice Monitoring ExtensionCompany Announcement - General
15-Feb-13 10:39PRNABERFORTH PARTNERS LLP - Form 8.3 - Ark Therapeutics Group plcMergers, Acquisitions and Disposals
12-Feb-13 12:25RNSHolding(s) in CompanyHolding(s) in Company


Regulatory news is displayed end of day, each day at 19:00.
Sign up for Live Prices





Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.